| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |